The global ESR analyzer market size is anticipated to exhibit growth at a CAGR of 4.8% over the forecast period from 2022 to 2032. Increasing prevalence of blood and infection-related diseases across the globe is set to drive growth.
Overall sales of ESR analyzers are expected to reach USD 63 Million in 2022 and be valued at USD 80 Million in 2032. Rising application of ESR analyzer to detect non-specific inflammation caused by diabetes, blood diseases, and collagen vascular diseases will propel the growth in the market.
| Report Attribute | Details |
|---|---|
| ESR Analyzer Market Expected Value (2022) | USD 63 Million |
| ESR Analyzer Market Anticipated Forecast Value (2032) | USD 80 Million |
| ESR Analyzer Market Projected Growth Rate (2022 to 2032) | 4.8% CAGR |
ESR (erythrocyte sedimentation rate) analyzers are extensively used to screen patients with fevers caused by muscle pain, arthritis, and other diseases for accurate and reliable reading. As per the study, advent of automated ESR analyzers for accurate reading is one of the key factors propelling the growth in the market.
As automated ESR analyzers are user friendly and effective for patient identification, healthcare professionals are increasing the adoption for rapid results and closed tube sample testing. Hence, key manufacturers are investing in research and development activities to develop advanced ESR analyzers to cater to the growing demand.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Technological advancements in the healthcare industry across the globe is one of the primary factor boosting the market. Besides this, preference for automated ESR analyzer for accurate and fast results will improve the sales of automated ESR analyzer in the market.
Moreover, development of healthcare infrastructure in countries such as India, China, and the USA will improve the adoption of advanced products. This is expected to drive the demand for automated ESR analyzers in the market.
Further, government across the globe are investing increasingly in advanced healthcare testing equipment. Besides this, surging adoption of advanced ESR analyzers in hospitals, diagnostic laboratories, and others will fuel the growth in the market.
ESR analyzers are complex instruments that require skilled resources for conducting blood test and for accurate results. Lack of adequate professionals in low-income countries might hamper the demand in the market.
Apart from this, high cost of ESR analyzers might also limit the sales in countries such as Brazil, UAE, South Korea, and other emerging economies. This is expected to create a negative impact in the market.
Principal Consultant
Presence of well-established healthcare industry in the USA and Canada is anticipated to expand the North America ESR analyzer market share in the evaluation period. The USA government is also expected to take certain initiatives to develop advanced healthcare testing equipment. This is expected to boost the market.
In addition to that, ESR analyzers are gaining impetus in North America stoked by their ability to provide accurate results and by growing prevalence of diabetes in the country. Moreover, rising incidence of blood-related diseases in geriatric population is giving impetus to the demand for ESR analyzers.
As per FMI, the USA is expected to account for lion’s share in the North America ESR analyzer market by 2032.
Improving healthcare system of India, China, and Japan is expected to improve the demand in Asia Pacific ESR analyzer market, opines FMI. Care centers and diagnostic laboratories are increasingly adopting advanced healthcare testing equipment in India and China.
Subsequently, presence of serval reimbursement policies and advent of automated ESR analyzer in South & East Asia will further push the sales in the market. Besides this, rising cases of blood-related diseases such as HIV, diabetes, syphilis, and others is creating growth opportunities for ESR analyzer manufacturers.
Spurred by these factors, Asia Pacific is considered to be the lucrative market for ESR analyzer. As per the study, due to the expansion of healthcare industry, key players are eyeing the India market, facilitating the growth in Asia Pacific.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the renowned companies present in the global ESR analyzer market include ALCOR Scientific Inc., Thermo Fisher Scientific, Caretium Medical Instruments Co., Limited, Hospitex Diagnostics, Beckman Coulter, Inc., Alifax, and Perlong Medical among others.
The global market is highly fragmented with the presence of a large number of international and regional companies. Key players are increasingly focusing on research and development activities to develop advanced testing equipment and broaden their product.
| Report Attribute | Details |
|---|---|
| Expected Market Value (2022) | USD 63 Million |
| Market Forecast Value (2032) | USD 80 Million |
| Growth Rate | CAGR of 4.8% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
Product Type, End Use, Region |
| Regions Covered |
North America; Latin America; Western Europe; Eastern Europe; APEJ; Japan; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASEAN, GCC, South Africa |
| Key Companies Profiled |
ALCOR Scientific Inc.; Thermo Fisher Scientific; Caretium Medical Instruments Co., Limited; Beckman Coulter, Inc.; Alifax; Perlong Medical; Hospitex Diagnostics |
| Customization | Available Upon Request |
The global ESR analyzer market is set to exceed USD 80 Million in 2032.
North America is set to lead the ESR analyzer market in the forecast period.
Thermo Fisher Scientific, Caretium Medical Instruments Co., Limited, Hospitex Diagnostics, Beckman Coulter, Inc. are some of the leading companies in the ESR analyzer market.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global ESR Analyzer Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 5. Global ESR Analyzer Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type 5.1. Automated ESR Analyzer 5.2. Semi-Automated ESR Analyzer 5.3. Manual ESR Analyzer 6. Global ESR Analyzer Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End Use 6.1. Hospitals 6.2. Diagnostic Laboratories 6.3. Academic Institutions 6.4. Others 7. Global ESR Analyzer Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 7.1. North America 7.2. Latin America 7.3. Europe 7.4. East Asia 7.5. South Asia & Pacific 7.6. MEA 8. North America ESR Analyzer Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9. Latin America ESR Analyzer Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10. Europe ESR Analyzer Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11. East Asia ESR Analyzer Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12. South Asia & Pacific ESR Analyzer Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13. MEA ESR Analyzer Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 14. Key Countries ESR Analyzer Market Analysis 15. Market Structure Analysis 16. Competition Analysis 16.1. ALCOR Scientific Inc. 16.2. Thermo Fisher Scientific 16.3. Caretium Medical Instruments Co., Limited 16.4. Hospitex Diagnostics 16.5. Beckman Coulter, Inc. 16.6. Alifax 16.7. Perlong Medical 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Testing Equipment Insights
View Reports
ESR Analyzer Market
